FDA Chief Urges Temporary Suspension of New Regulatory Fees
Manila: The Food and Drug Administration (FDA) has called on the Department of Health (DOH) to approve the immediate suspension of increased fees for facility registration and certificate of product registration for health products. This request comes as the FDA seeks to reassess certain provisions of Administrative Order No. 2024-0016, which mandates these increased fees. According to Philippines News Agency, FDA Director General Paolo Teston emphasized the need for the proposed suspension to be effective seven days following the DOH’s approval. The suspension is set to last for 60 days unless the DOH secretary decides to lift or extend it.